Dr. Maggi Price, PhD
Claim this profileStudies Acceptance
Studies Knowledge, Attitudes, and Practices (KAP)
1 reported clinical trial
1 drug studied
More about Maggi Price, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Maggi Price, PhD has experience with
- Gender-Affirming Psychotherapy (GAP) Training
Breakdown of trials Maggi Price, PhD has run
Knowledge, Attitudes, and Practices (KAP)
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maggi Price, PhD specialize in?
Maggi Price, PhD focuses on Acceptance and Knowledge, Attitudes, and Practices (KAP). In particular, much of their work with Acceptance has involved treating patients, or patients who are undergoing treatment.
Is Maggi Price, PhD currently recruiting for clinical trials?
No, Maggi Price, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Maggi Price, PhD has studied deeply?
Yes, Maggi Price, PhD has studied treatments such as Gender-Affirming Psychotherapy (GAP) Training.
What is the best way to schedule an appointment with Maggi Price, PhD?
Apply for one of the trials that Maggi Price, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.